N.N. Blokhin Russian Cancer Research Center / Российский онкологический научный центр им. Н. Н. Блохина

Research facility


Location: Moscow / Moskau, Russian Federation (RU) RU

ISNI: -

ROR: https://ror.org/00ab9fg88

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. (2021) Bottomley A, Coens C, Mierzynska J, Blank CU, Mandalà M, Long GV, Atkinson VG, et al. Journal article Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. (2021) Eggermont AM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, et al. Journal article Challenging the prognostic impact of the new WHO and TNM classifications with special emphasis on HPV status in penile carcinoma (2019) Hölters S, Khalmurzaev O, Pryalukhin A, Loertzer P, Janssen M, Heinzelbecker J, Ueberdiek S, et al. Journal article Quality assurance guidelines for interstitial hyperthermia (2019) Trefna HD, Schmidt M, Van Rhoon GC, Kok HP, Gordeyev SS, Lamprecht U, Marder D, et al. Journal article Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine (2014) Grob JJ, Amonkar MM, Martin-Algarra S, Demidov LV, Goodman V, Grotzinger K, Haney P, et al. Journal article Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma (2014) Pisareva E, Gutkina N, Kovalenko S, Kuehnapfel S, Hartmann A, Heinzerling L, Schneider-Stock R, et al. Journal article
‹ 1 2 ›